Detalhe da pesquisa
1.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048793
2.
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
Breast Cancer Res Treat
; 205(2): 267-279, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453781
3.
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Int J Cancer
; 152(5): 921-931, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161271
4.
PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells.
Int J Mol Sci
; 24(20)2023 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37895093
5.
Differential Sensitivity of Germline and Somatic BRCA Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer.
Int J Mol Sci
; 24(18)2023 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762485
6.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183733
7.
Sexual quality of life assessment in young women with breast cancer during adjuvant endocrine therapy and patient-reported supportive measures.
Support Care Cancer
; 30(4): 3633-3641, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028721
8.
Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients.
Breast Cancer Res Treat
; 186(3): 705-713, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452553
9.
Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer.
BMC Cancer
; 21(1): 815, 2021 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34266398
10.
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer.
Cancer
; 126(13): 3132-3139, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286687
11.
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer.
Clin Chem
; 66(8): 1093-1101, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712650
12.
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.
Breast Cancer Res
; 21(1): 121, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727113
13.
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
Lancet Oncol
; 19(8): 1117-1125, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026000
14.
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.
Breast Cancer Res Treat
; 157(2): 307-318, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27167986
15.
Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.
Int J Gynecol Cancer
; 26(5): 912-7, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27051055
16.
Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility study.
Cancer Rep (Hoboken)
; 6(1): e1732, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302744
17.
First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept study.
Cancer Med
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38132919
18.
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
J Clin Oncol
; 41(30): 4768-4778, 2023 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37643382
19.
[Combining surgery and medical treatments for ovarian cancer: Is there an optimal strategy?] / Combinaison de la chirurgie et du traitement médical du cancer de l'ovaire : y a-t-il une stratégie optimale ?
Bull Cancer
; 109(2): 197-215, 2022 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-35027164
20.
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
JAMA Netw Open
; 5(9): e2231170, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107428